Zenas BioPharma, Inc. (ZBIO)
NASDAQ·Healthcare·Biotechnology
$27.10
-0.73%
Mkt Cap $1.78B
Analyst Ratings
Buy
7
Hold
2
Sell
0
Price Target (9 analysts)
$43.50
Range $32.00 – $55.00
Implied Upside
+60.5%
Consensus $43.50 vs current $27.10
NASDAQ·Healthcare·Biotechnology
$27.10
-0.73%
Mkt Cap $1.78B
Buy
7
Hold
2
Sell
0
Price Target (9 analysts)
$43.50
Range $32.00 – $55.00
+60.5%
Consensus $43.50 vs current $27.10